Bruker Corporation Acquires IonSense Inc.
April 6, 2022
Bruker Corporation has acquired IonSense Inc., the developer of ambient DART (Direct Analysis in Real Time) ionization technology. Bruker said the acquisition will accelerate development and applications of DART-MS across applied markets such as food analysis and forensics by leveraging Bruker's instrument platform and resources.
- Buyers
- Bruker Corporation
- Targets
- IonSense Inc.
- Industry
- Manufacturing
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Industrial Control Solutions Acquires Duro-Sense Corporation
October 20, 2025
Manufacturing
Industrial Control Solutions (ICS), a Bristol, Connecticut-based instrumentation platform and portfolio company of LDR Partners LP, has acquired Duro-Sense Corporation, a Carson, California manufacturer of thermocouples, RTDs, and custom temperature measurement assemblies. The add-on expands ICS's capabilities into temperature measurement, strengthens its presence on the U.S. West Coast, and enhances its position in aerospace, defense, power generation, and industrial OEM markets. The deal closed October 20, 2025.
-
Bruker Corporation Acquires Nion
January 3, 2024
Manufacturing
Bruker Corporation has acquired Nion, a Kirkland, Washington developer and manufacturer of high-end scanning transmission electron microscopes (STEM), including the UltraSTEM line and advanced EELS technology. The acquisition strengthens Bruker's materials science instrumentation portfolio and provides capabilities for electron diffraction crystallography; Nion reported approximately $8 million in revenue in 2023. Financial terms were not disclosed.
-
Bruker Corporation Acquires NanoString Technologies Business
May 6, 2024
Medical Devices
Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.
-
Bruker Acquires Dynamic Biosensors GmbH
October 2, 2024
Biotechnology
Bruker Corporation has acquired Dynamic Biosensors GmbH, a Munich-based developer of single-cell interaction cytometry and biosensor instruments, to strengthen Bruker’s biosensors portfolio. The deal combines Dynamic Biosensors’ heliXcyto and heliX+ technologies with Bruker’s high-throughput SPR systems to expand capabilities and product offerings for drug discovery and biopharma research; financial terms were not disclosed.
-
Bruker Corporation Acquires Neurescence Inc.
November 12, 2022
Medical Devices
Bruker Corporation has signed a definitive agreement to acquire 100% of Neurescence Inc., a Toronto-based developer of ultralight fiber‑bundle Multiscopes (Chromatone) for multi-region optical functional neuroimaging. The acquisition strengthens Bruker's preclinical neuroscience imaging capabilities and complements its existing Ultima multiphoton solutions and recently acquired Inscopix products; financial terms were not disclosed.
-
Bruker Corporation Acquires Spectral Instruments Imaging
February 6, 2024
Medical Devices
Bruker Corporation has acquired Spectral Instruments Imaging LLC, a Tucson-based maker of preclinical in‑vivo optical imaging systems, to broaden Bruker BioSpin's preclinical imaging portfolio. Financial terms were not disclosed; SII generated over $10 million in revenue in 2023 and will expand Bruker's capabilities in bioluminescence, fluorescence and X‑ray preclinical imaging.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.